Chemical-structure (Chemical Structure)
Topiramate Tablet, Film Coated
Product Images NDC 71335-0325
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 71335-0325). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure-1jpg (Figure 1)
The text describes cumulative rates for time to first seizure for two different doses of Topiramate (50mg/day and 400mg/day) over a period of 500 days. A statistical significance is mentioned with a p-value of 0.0002. There is a graph with time in days on the x-axis and cumulative rate on the y-axis.*
Figure-2 (Figure 2)
Label Image (Lbl713350325)
This appears to be a label of Topiramate, a prescription medication manufactured by Sun Pharmaceutical Industries Ltd. The medication is a 100mg tablet that comes in a yellow, round shape, with an imprint "S;711". It is recommended to be stored at room temperature between 20°-25°C (68°-77°F) and kept out of reach of children. The label includes an expiration date of MM/YY and the medication is packaged in a bottle containing 60 tablets with the National Drug Code (NDC) 7133503251 03294601523487.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
